Impact of Long-Acting HIV Prevention Drugs

Video

A panel of experts discuss the role of PrEP in HIV prevention with a focus on current and newly approved options.

Recent Videos
1 KOL is featured in this program
1 KOL is featured in this program
1 KOL is featured in this program
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this program
1 KOL is featured in this program
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
Preparing for PrEP: The Implications of PrEP Medicare Coverage Transition for Pharmacies

Preparing for PrEP: The Implications of PrEP Medicare Coverage Transition for Pharmacies

Spreeha Choudhury, PharmD, JD
July 21st 2024
Article
Public Health Matters: The Pharmacist's Role in the HIV Space, Removing Barriers, Racial Disparities

Public Health Matters: The Pharmacist's Role in the HIV Space, Removing Barriers, Racial Disparities

February 7th 2024
Podcast
Undercover Shoppers Experience Challenges in Accessing Legal, Clean OTC Needles in Arizona

Undercover Shoppers Experience Challenges in Accessing Legal, Clean OTC Needles in Arizona

Dylan DeCandia, PharmD, RPh
May 31st 2024
Article
Pharmacy Focus: Public Health Matters- The Importance of PRIDE in Building an Inclusive Public Health Community

Pharmacy Focus: Public Health Matters- The Importance of PRIDE in Building an Inclusive Public Health Community

June 23rd 2022
Podcast
FDA approval seal -- Image credit: Aquir | stock.adobe.com

FDA Approves Dolutegravir/Lamivudine for Treatment of Adolescents With HIV-1 Infection

Gillian McGovern, Assistant Editor
April 8th 2024
Article
Concept of FDA Food and Drug Administration | Image Credit: wladimir1804 - stock.adobe.com

FDA Approves Rilpivirine for Treatment of HIV for Pediatric Patients 2 and Older

Ashley Gallagher, Associate Editor
March 21st 2024
Article